On the other hand, the methylation of the RIZ1 promoter is closely associated with the loss or reduction in RIZ1 mRNA expression in breast, hepatocellular, colon, and lung cancer cell lines, as well as in hepatocellular carcinoma tissues. This evidence concerns the gene PRDM2 and lung cancer.